Speaker illustration

Professor Chris Packard

Glasgow (United Kingdom of Great Britain & Northern Ireland)

PCSK9 inhibitors: the evidence-based story

Event: ESC CONGRESS 2017

Topic: Atherosclerosis

Session type: Satellite Symposium - Experts on the Spot

Thumbnail

This platform is supported by

logo Novo Nordisk